Tumor-host histopathologic variables, stromal myofibroblasts and risk score, are significantly associated with recurrent disease in tongue cancer

Cancer Science

Volumn 101, Issue 1, 2010, Pages 274-280

  Vered, Marilena ^a,b   Dobriyan, Alex ^a   Dayan, Dan ^b   Yahalom, Ran ^a   Talmi, Yoav P ^a   Bedrin, Lev ^a   Barshack, Iris ^a   Taicher, Shlomo ^a  

^a SHEBA MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; KI 67 ANTIGEN; UVOMORULIN;

ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER RECURRENCE; CANCER RISK; CANCER SURVIVAL; CARCINOMA CELL; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; MAJOR CLINICAL STUDY; MALE; MYOFIBROBLAST; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SCORING SYSTEM; STROMA; TONGUE CANCER;

ADULT; AGED; AGED, 80 AND OVER; CADHERINS; EPITHELIUM; FEMALE; FIBROBLASTS; HUMANS; MALE; MESODERM; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RISK; STROMAL CELLS; TONGUE NEOPLASMS;

EID: 71949119461     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2009.01357.x     Document Type: Article

References (30)

1. Brandwein-Gensler M, Teixeira MS, Lewins CM. Oral squamous cell carcinoma. Histologic risk assessment, but not margin status, is strongly predictive of local disease-free and overall survival. Am J Surg Pathol 2005, 29:167-78.
2. De Wever O, Mareel M. Role of tissue stroma in cancer cell invasion. J Pathol 2003, 200:429-47.
3. Jewett A, Head C, Cacalano NA. Emerging mechanisms of immunosuppression in oral cancers. J Dent Res 2006, 85:1061-73.
4. De Wever O, Demetter P, Mareel M, Bracke M. Stromal myofibroblasts are drivers of invasive cancer growth. Int J Cancer 2008, 123:2229-38.
5. Voulgari A, Pintzas A. Epithelial-mesenchymal transition in cancer metastasis: mechanisms, markers and strategies to overcome drug resistance in the clinic. Biochimica Biophysica Acta 2009, 1796:72-90.
6. Thiery JP, Sleeman JP. Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol 2006, 7:131-42.
7. Nawshad A, LaGamba D, Polad A. Transforming growth factor-β signaling during epithelial-mesenchymal transformation: implications for embryogenesis and tumor metastasis. Cells Tissues Organs 2005, 179:11-23.
8. Vered M, Allon I, Buchner A, Dayan D. Stromal myofibroblasts accompany modifications in the epithelial phenotype of tongue dysplastic and malignant lesions. Cancer Microenviron 2009, doi
9. Johnson N, Francheschi S, Ferlay J, Barnes LB, Eveson JW, Reichart P, Sidransky D. Squamous cell carcinoma. World Health Organization Classification of Tumors, Head and Neck Tumours, Pathology and Genetics 2005, 168-75. In, eds, Lyon, IARCPress
10. Bankfalvi A, Krassort M, Vegh A, Felszeghi E, Piffko J. Deranged expression of the E-cadherin/beta-catenin complex and the epidermal growth factor receptor in the clinical evolution and progression of oral squamous cell carcinomas. J Pathol Med 2002, 31:450-7.
11. Batsakis JC. Surgical excision margins: a pathologist's perspective. Adv Anat Pathol 1999, 6:140-8.
12. Muller S, Pan Y, Li R, Chi AC. Changing trends in oral squamous cell carcinoma with particular reference to young patients: 1971-2006. The Emory University experience. Head Neck Pathol 2008, 2:60-6.
13. Conway DI, Stockton DL, Warnakulasuriya KA, Ogden G, Macpherson LM. Incidence of oral and oropharyngeal cancer in United Kingdom (1990-1999) - recent trends and regional variation. Oral Oncol 2006, 42:586-92.
14. Schantz SP, Yu GP. Head and neck cancer incidence in young Americans, 1973-1997, with a special analysis of tongue cancer. Arch Otolaryngol Head Neck Surg 2002, 128:268-74.
15. Sathyan KM, Sailasree R, Jayasurya R. Carcinoma of tongue and the buccal mucosa represent different biological subentities of the oral carcinoma. J Cancer Res Clin Oncol 2006, 132:601-9.
16. Bell RB, Kademani D, Homer L, Dierks EJ, Potter BE. Tongue cancer: is there a difference in survival compared with other subsites in the oral cavity? J Oral Maxillofac Surg 2007, 65:229-36.
17. Sutton DN, Brown JS, Rogers SN, Vaughan ED, Woolgar JA. The prognostic implications of the surgical margins in oral squamous cell carcinoma. Int J Oral Maxillofac Surg 2003, 32:30-4.
18. Woolgar JA, Triantafyllou A. Pitfalls and procedures in the histopathological diagnosis of oral and oropharyngeal squamous cell carcinoma and a review of the role of pathology in prognosis. Oral Oncol 2009, 45:361-85.
19. Smeele LE, Leemans CR, Langendijk JA. Positive surgical margins in neck dissection specimens in patients with head and neck squamous cell carcinoma and the effect of radiotherapy. Head Neck 2000, 22:559-63.
20. Surowiak P, Murawa D, Materna V. Occurrence of stromal myofibroblasts in the invasive ductal breast cancer tissue is an unfavorable prognostic factor. Anticancer Res 2007, 27(4C):2917-24.
21. Tsujino T, Seshimo I, Yamamoto H. Stromal myofibroblasts predict disease recurrence for colorectal cancer. Clin Cancer Res 2007, 3:2082-90.
22. Kellermann MG, Sobral LM, da Silva SD. Myofibroblasts in the stroma of oral squamous cell carcinoma are associated with poor prognosis. Histopathology 2007, 51:849-53.
23. Kawashiri S, Tanaka A, Noguchi N. Significance of stromal dsmoplasia and myofibroblast appearance at the invasive front in squamous cell carcinoma of the oral cavity. Head Neck 2009, 31:1346-53.
24. Baum M. Breast cancer - a challenge to the contemporary paradigm. Acta Oncol 1996, 35(Suppl.):3-6.
25. Guarino M. Epithelial-mesenchymal transition and tumor invasion. Int J Biochem Cell Biol 2007, 39:2153-60.
26. Yang J, Weinberg RA. Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Dev Cell 2008, 14:818-29.
27. Hugo H, Ackland ML, Blik T. Epithelial-mesenchymal and mesenchymal-epithelial transitions in carcinoma progression. J Cell Physiol 2007, 213:374-83.
28. Tlsty TD, Coussens LM. Tumor stroma and regulation of cancer development. Annu Rev Pathol 2006, 1:119-50.
29. Micke P, Ostman A. Tumour-stroma interaction: cancer-associated fibroblasts as novel targets in anti-cancer therapy? Lung Cancer 2004, 45(Suppl. 2):S163-75.
30. Hanna E, Quick J, Libutti SK. The tumor microenvironment: a novel target for cancer therapy. Oral Dis 2009, 15:8-17.